Explore /
Poster
/ Tumor-directed PET imaging of metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled antiprostate-specific membrane antigen (PSMA) antibody J591.

Tumor-directed PET imaging of metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled antiprostate-specific membrane antigen (PSMA) antibody J591.

Authors

Jarett L. Feldman

Memorial Sloan Kettering Cancer Center, New York, NY

Jarett L. Feldman , Michael J. Morris , Danny F. Martinez , Scott T. Tagawa , David M. Nanus , Stephen Barnett Solomon , Jorge A. Carrasquillo , Victor E. Reuter , Jason Stuart Lewis , Joseph A. O' Donoghue , Susan F. Slovin , Dana E. Rathkopf , Mithat Gonen , Volkan Beylergil , Jeremy C. Durack , Sarah M. Cheal , Neil Harrison Bander , Howard I. Scher , Steven M. Larson , Neeta Pandit-Taskar

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Prostate) Cancer

Track

Genitourinary Cancer

Sub Track

Prostate Cancer

Clinical Trial Registration Number

NCT01543659

Citation

J Clin Oncol 33, 2015 (suppl; abstr 5054)

DOI

10.1200/jco.2015.33.15_suppl.5054

Abstract #

5054

Poster Bd #

Abstract Disclosures

Similar Posters

Poster

2015 Genitourinary Cancers Symposium